mortality/aging
• median and maximal survival of 269 and 438 days
|
behavior/neurological
• starting around 9 months of age, mutants develop an abnormal gait with a shortened stride and splaying of the rear limbs
• eventually develop a hunched appearance and a side-to-side sway as they walk
|
nervous system
• levels of the small proteolipid, subunit C of mitochondrial ATP synthase (SCMAS ), are slightly elevated in the Purkinje cell layer of the cerebellar cortex at 4 months of age
|
cellular
• later onset of neuronal ceroid lipofuscinosis disease and slower progression than in homozygous Tpp1tm1Plob mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
neuronal ceroid lipofuscinosis 2 | DOID:0110726 |
OMIM:204500 |
J:136105 |